SEC Form 4 · accession 0001209191-18-031170
ImmunityBio, Inc. · IBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Gorlin
Director
Period of report
May 15, 2018
Accepted (ET)
May 17, 2018 · 6:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 15, 2018 | S | 26,835 | $4.1323 | D | 494,885 | I | By spouse |
| Common StockF2 | May 16, 2018 | S | 16,200 | $4.0515 | D | 478,685 | I | By spouse |
| Common StockF3 | May 17, 2018 | S | 38,708 | $4.0025 | D | 439,977 | I | By spouse |
| Common Stock | holding | — | — | — | 246,280 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average share price of an aggregate total of 26,835 shares sold in the price range of $4.08 to $4.20 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2Represents the weighted average share price of an aggregate total of 16,200 shares sold in the price range of $4.04 to $4.11 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Represents the weighted average share price of an aggregate total of 38,708 shares sold in the price range of $4.00 to $4.03 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.